CBM588 in Improving Clinical Outcomes in Participants Who Have Undergone Donor Hematopoietic Stem Cell Transplant

Condition:   Allogeneic Hematopoietic Stem Cell Transplantation Recipient Interventions:   Other: Best Practice;   Drug: CBM588 Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials